Resultados de la búsqueda 1-10 of 16743 for Cystinosis+agents

  1. Radiología - Ensayos clínicos - Mayo Clinic

    The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... agent in patients with advanced unresectable or metastatic solid tumors ... agents for the treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Given the restricted expression profile, FAP is a promising target for peptide-targeted radionuclide imaging and therapeutic agents. Phase 1 of this study ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... agents for the treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell ... agent in patients with advanced unresectable or metastatic solid tumors ...

  5. Radiología - Ensayos clínicos - Mayo Clinic

    The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... agents for the treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Study of Leukemia Inhibitory Factor Biomarker Monitoring ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Given the restricted expression profile, FAP is a promising target for peptide-targeted radionuclide imaging and therapeutic agents. Phase 1 of this study ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    ... agents for the treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). Pre-myeloid Cancer and Bone Marrow Failure Clinic Study.

  9. Hematología - Ensayos clínicos - Mayo Clinic

    ... agents for the treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). The Effects of Acute and Chronic Exercise on Immune Phenotype ...

  10. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY). Rochester, Minn. The purpose of this study is to further ...